Cambridge Isotope L-Glutamine
ID: NIMH25001360Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

All Other Basic Organic Chemical Manufacturing (325199)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/c6be40fd1c444c51a683bf12e66751c8/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide L-Glutamine enriched with stable isotope 13C for neuroscience research. The procurement aims to secure domestically manufactured chemicals that are essential for enhancing carbon-13 MR spectroscopy signals, which are critical for studying brain metabolism and measuring important metabolites. This initiative underscores the importance of maintaining a domestic supply of these chemicals to support ongoing research efforts at NIH and NIMH. Interested parties must submit their responses, including company information and capability statements, electronically to Joseph Kennedy at joseph.kennedy@nih.gov by January 22, 2025, as the anticipated contract duration is 12 months.

    Point(s) of Contact
    Joseph Kennedy
    joseph.kennedy@nih.gov
    Marlene Milgram
    (301) 594-0864
    marlene.milgram@nih.gov
    Files
    Title
    Posted
    D_25-001360_Sources Sought.pdf
    The government has issued a Sources Sought Notice for L-Glutamine from Cambridge Isotope, classified under NAICS code 325199. This notice aims to assess the availability and capability of small businesses, including various classifications such as HUBZone, veteran-owned, and woman-owned entities, to provide domestically manufactured chemicals enriched with stable isotope 13C for neuroscience research. The chemicals are essential for enhancing the intensity of carbon-13 MR spectroscopy signals used to study brain metabolism, with specific requirements for 99% enrichment and certification of analysis. The anticipated contract duration is 12 months, and responses must include detailed company information, capability statements, and size classification according to relevant guidelines. The government seeks to identify qualified small business sources to determine potential acquisition strategies, including set-asides. Although this notice does not guarantee a solicitation or contract award, it emphasizes the critical need for these chemicals in ongoing research and the importance of domestic supply capabilities. Responses are to be submitted electronically to the provided contact by January 22, 2025.
    Lifecycle
    Title
    Type
    Cambridge Isotope L-Glutamine
    Currently viewing
    Sources Sought
    Similar Opportunities
    SOURCES SOUGHT: Mass Spectrometry Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA), is seeking qualified small business sources for the procurement of specialized Mass Spectrometry Reagents aimed at advancing research on Alzheimer’s Disease and related dementias. The objective is to establish a national resource of isogenic induced pluripotent stem cell (iPSC) lines to study genetic mutations associated with these diseases, thereby accelerating mechanistic discovery. This procurement is critical for enhancing the understanding of Alzheimer’s disease mechanisms and includes specific requirements for HPLC columns and related supplies, with the first delivery expected by July 7, 2025, and additional options extending to July 2027. Interested parties should submit their capability statements to Rashiid Cummins at Rashiid.Cummins@nih.gov by January 21, 2025, at 3:00 PM Eastern Time.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug products. The objective of this procurement is to secure high-quality formulated drug products to support preclinical, IND-enabling, and clinical studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is critical for advancing therapeutic development and enhancing the drug development pipeline, which is vital for public health. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can reach out to Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    NUcleic acid Linked Immuno-Sandwich Assay Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of NUcleic acid Linked Immuno-Sandwich Assay Reagents, aimed at enhancing biomarker discovery for neurodegenerative disease research at the Center for Alzheimer’s Disease and Related Dementias (CARD). The acquisition includes the Alamar NULISAseq Inflammation Panel, with a requirement for 30 units that must demonstrate high sensitivity in analyzing over 250 proteins from minimal sample volumes, ensuring compatibility with the ARGO proteomics platform. This procurement is critical for advancing research capabilities in the detection of biomarkers related to Alzheimer’s Disease and Related Dementias (ADRD). Interested vendors must submit their quotations by January 22, 2025, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@nida.nih.gov, and must comply with all specified federal regulations and provisions outlined in the solicitation.
    Assay Kits for Lumipulse instrument
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for measuring abeta42, abeta40, and pTau 217, which will support ongoing research into cognitive decline and neurodegeneration using samples from the Baltimore Longitudinal Study of Aging. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on January 15, 2025, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547. This procurement is conducted under simplified acquisition procedures and is open to all qualified offerors without set-aside restrictions.
    Maintenance service for Mass Spectrometers and components
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide maintenance services for Mass Spectrometers and associated components utilized by the National Institute on Aging (NIA). The procurement aims to ensure the proper functioning of critical instruments, including the Q Exactive HF and Orbitrap Eclipse Tribid, which are essential for ongoing research in discovery proteomics and aging studies. Interested vendors must submit a capability statement detailing their qualifications, including employee numbers and relevant experience, by January 17, 2025, at 5:00 PM EST, to Iris Merscher at iris.merscher@nih.gov. This notice is a Sources Sought announcement and does not constitute a solicitation for proposals.
    Carbon Dioxide Gas Supply and Service for CO2 Tank Farm in Bldg 10 E Wing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking qualified vendors to supply and service carbon dioxide gas for the CO2 Tank Farm located in Building 10 E Wing, Bethesda, Maryland. This procurement involves a renewal requirement for a continuous supply of carbon dioxide gas essential for cell culture incubators and other critical scientific equipment in NIAID laboratories, covering a one-year period from approximately February 1, 2025, to January 31, 2026. The contract will be awarded based on technical capability and price, with a firm fixed price purchase order anticipated. Interested parties must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by January 8, 2025, at 5:00 PM EST, and can contact Dana Monroe at dana.monroe@nih.gov for further information.
    Fieldline 64 Sensor
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide equipment and services for the development of a non-invasive magnetocardiography (MCoG) array, focusing on the Fieldline V3 Sensor. The project aims to enhance the measurement of human neurophysiology by supplying 64 sensors and related hardware, as well as research and design services, including the prototyping of a compound gradiometer. This initiative is critical for advancing the understanding of brain function through improved non-invasive observation techniques. Interested parties must submit their qualifications and capabilities by January 22, 2025, and can contact Joseph Kennedy at joseph.kennedy@nih.gov or Marlene Milgram at marlene.milgram@nih.gov for further information.
    Biological Therapeutics Product Development Subject Matter Expert Consultants
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for consulting services from subject matter expert (SME) consultants to support the development of biological therapeutics. The primary objective is to engage experts who can provide technical recommendations across various phases of drug discovery and development, including chemistry, regulatory affairs, and clinical trial design, particularly for novel therapeutics aimed at neurological disorders and rare genetic conditions. This initiative is crucial for advancing NIH's drug discovery programs, ensuring that innovative biologics progress efficiently through clinical evaluation. Interested vendors should note that the contract has a performance period of one year, with two optional extensions, and proposals must be submitted by January 27, 2025. For further inquiries, potential bidders can contact Shayna Simpson at shayna.simpson@nih.gov or Kelly Dempsey at kelly.dempsey@nih.gov.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    A--National Gene Vector Biorepository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the National Gene Vector Biorepository (NGVB) contract, aimed at supporting gene therapy research for the National Heart, Lung, and Blood Institute (NHLBI). The contract will involve archiving biological specimens, conducting DNA and RNA extractions, and developing assays, while ensuring compliance with FDA regulations and Good Laboratory Practices (GLP). This initiative is critical for advancing gene therapy capabilities and enhancing research resources, with an expected proposal submission deadline of January 10, 2025, and a revised due date for proposals set at 2:00 PM EST on January 15, 2025. Interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or +1 301 496 2153 for further information.